Title | UNEXPLAINED BLEEDING? |
Brand | NOVO NORDISK PHARMA GMBH |
Product/Service | NOVOSEVEN® |
Category |
E02. Dierct to Healthcare Professional |
Entrant
|
PEIX AGENTUR FüR DESIGN & KOMMUNIKATION Berlin, GERMANY
|
Idea Creation
|
PEIX AGENTUR FüR DESIGN & KOMMUNIKATION Berlin, GERMANY
|
Credits
Karsten Rzepka |
Peix Agentur für Design und Kommunikation GmbH |
Founder & CEO |
Christine Herbst |
Peix Agentur für Design und Kommunikation GmbH |
Associate Creative Director |
Kathrin Bott |
Peix Agentur für Design und Kommunikation GmbH |
Art Director |
Heiko Laschitzki |
Heiko Laschitzki |
Photographer |
Describe any restrictions or regulations regarding Healthcare/RX/Pharma communications in your country/region including:
RX communication is strong regulated and just direct to Healthcare Professionals allowed. There are also strong compliance rules in the communication direct to Healthcare Professionals.
Describe the target audience and why your work is relevant to them.
Healthcare professionals, e. g. surgeons and haemostaseologists; even experienced emergency staff can miss the signs of acquired haemophilia – with drastic results.
Translation: Provide a full English translation of any text.
Headline:
Unexplained bleeding is fatal for one in five patients.*
Subline:
It’s in your hands: Save lives and stop any bleeding with NovoSeven®!
The gold standard of first-line therapy for acquired haemophilia.
Annotation:
*Acquired haemophilia, either as a direct result of blood loss or indirectly related to acquired haemophilia.
Copy:
(local SMPC NovoSeven®)
Sender:
novo nordisk®
Brand:
NovoSeven®
recombinant factor VIIa